GET THE APP

..

Archives of Surgical Oncology

ISSN: 2471-2671

Open Access

The Future of Targeted Therapy for Leiomyosarcoma: A Promising Horizon

Abstract

Vlad Bratucu*

Leiomyosarcoma (LMS), a malignant soft tissue tumor arising from smooth muscle cells, presents a significant therapeutic challenge due to its aggressive nature and limited treatment options. Conventional treatments such as surgery, chemotherapy, and radiation have shown limited efficacy, prompting the exploration of novel therapeutic strategies. Among these, targeted therapy has emerged as a promising approach, offering the potential to improve outcomes for patients with LMS. In this article, we delve into the current landscape of targeted therapy for LMS and explore the promising future directions in this field.

HTML PDF

Share this article

arrow_upward arrow_upward